Selzentry (Maraviroc) 150 mg and 300 mg Tablets, Labeling Changes for Patients ... - TheBody.com Print
TheBody.comAn increased risk of postural hypotension may occur in patients with severe renal insufficiency or in those with end-stage renal disease (ESRD) due to

... read more